GEM-4C 558 -4%
GPT-61S 555 -3.8%
CL-SN55 553 -3.8%
CL-OP55 551 -4%
GPT-61TERR 547 -3.5%
GEM-4CM 546 -4%
CL-OP55EH 542 -3.9%
GPT-61SOLXH 541 -3.6%
GPT-61SOLH 527 -3.7%
CL-SN55XH 523 -3.5%
GEM-4CL 520 -3.9%
GPT-61TERRXH 507 -3.4%
CL-OP55H 506 -4%
GPT-61SOLM 500 -3.5%
KIMI-K31P 499 -3.5%
GEM-4AR 498 -3.9%
GPT-61TERRH 490 -3.2%
CL-OP55M 483 -3.6%
MUSE-WONDFUL 479 -3.8%
CL-SN55H 467 -3.3%
CL-HK55 463 -2.9%
GPT-61TERRM 462 -3.1%
GPT-6A 451 -4.7%
MUSE-WOND 451 -3.6%
CL-HK55XH 450 -3%
GPT-6ASTRXH 440 -4.8%
GROK-47 440 -3.1%
GROK-47H 438 -2.9%
GPT-6ASTRH 437 -4.8%
DSK-V-340615 436 -2.9%
QWEN-38X 428 -2.9%
GPT-61SOLL 423 -3.2%
GLM-53 420 -3%
MIMO-V26P 420 -2.6%
CL-HK55H 419 -2.8%
LING-31F1019 417 -2.6%
GEM-38F 416 -2.8%
GPT-6ASTRM 415 -4.6%
MMAX-M31F 414 -2.8%
GEM-38FM 412 -2.8%
GPT-61TERRNO 411 -2.8%
GROK-47L 410 -2.8%
DSK-V-3E48BD 410 -2.6%
GPT-6L 407 -2.6%
GLM-53F 407 -2.6%
STEP-5 405 -2.6%
CL-FABL51XH 403 -4.7%
GPT-61TERRL 403 -2.9%
MIMO-V26F 401 -2.4%
CL-FABL51 399 -4.5%
CL-SN55M 395 -2.9%
CL-OP55L 393 -3.4%
MIST-LARG4 390 -2.7%
CL-FABL51H 386 -4.5%
CL-HK55M 386 -2.3%
GPT-6LUNAXH 377 -2.6%
MUSE-SPAROPE 375 -2.6%
MIST-LARG4M 371 -2.4%
DSK-V4P 365 -2.4%
GPT-6LUNAH 365 -2.1%
GLM-53L 364 -2.4%
CL-SN55L 362 -2.7%
GEM-38FL 361 -2.4%
GPT-6ASTRL 359 -4.5%
CL-FABL51M 359 -4.5%
QWEN-827B 349 -2.2%
CL-HK55L 347 -2%
MMAX-M3 345 -2%
GPT-6LUNAM 344 -2.3%
DSK-V-02811D 344 -2%
K2-HORI375BA 342 -2%
REFL-BEAM 338 -2%
QWEN-827BM 332 -1.8%
CL-FABL51L 329 -4.4%
QWEN-827BL 320 -1.8%
NEMO-35SUPEV 313 -1.9%
INKL 295 -1.7%
NVID-NEMO3UL 295 -1.3%
GEM-35FLITE 295 -1.3%
GPT-6LUNAL 287 -1.4%
GPT-6LUNANON 286 -1%
NANB-333B 285 -2.7%
QWEN-827BNON 282 -1.4%
COMM-APLUS 266 -1.1%
MUSE-GLIM 263 -1.1%
NEMO-35LIGH 261 -0.8%
GRAN-428B 258 -0.8%
MIST-SMAL4 252 -0.4%
INKL-SM 235 -2.5%
GEMM-431B 225 —
GEMM-4E4B 225 —
GEMM-4E4BNON 225 —
LING-30TINY 225 —
MINI-33B 225 —
NORT-MCODE 225 —
NOVA-MICR 225 —
NVID--ADE3B4 225 —
QWEN-54B 225 —
QWEN-54BNONR 225 —
TINY-AYAGLOB 225 —
GEM-4C 558 -4%
GPT-61S 555 -3.8%
CL-SN55 553 -3.8%
CL-OP55 551 -4%
GPT-61TERR 547 -3.5%
GEM-4CM 546 -4%
CL-OP55EH 542 -3.9%
GPT-61SOLXH 541 -3.6%
GPT-61SOLH 527 -3.7%
CL-SN55XH 523 -3.5%
GEM-4CL 520 -3.9%
GPT-61TERRXH 507 -3.4%
CL-OP55H 506 -4%
GPT-61SOLM 500 -3.5%
KIMI-K31P 499 -3.5%
GEM-4AR 498 -3.9%
GPT-61TERRH 490 -3.2%
CL-OP55M 483 -3.6%
MUSE-WONDFUL 479 -3.8%
CL-SN55H 467 -3.3%
CL-HK55 463 -2.9%
GPT-61TERRM 462 -3.1%
GPT-6A 451 -4.7%
MUSE-WOND 451 -3.6%
CL-HK55XH 450 -3%
GPT-6ASTRXH 440 -4.8%
GROK-47 440 -3.1%
GROK-47H 438 -2.9%
GPT-6ASTRH 437 -4.8%
DSK-V-340615 436 -2.9%
QWEN-38X 428 -2.9%
GPT-61SOLL 423 -3.2%
GLM-53 420 -3%
MIMO-V26P 420 -2.6%
CL-HK55H 419 -2.8%
LING-31F1019 417 -2.6%
GEM-38F 416 -2.8%
GPT-6ASTRM 415 -4.6%
MMAX-M31F 414 -2.8%
GEM-38FM 412 -2.8%
GPT-61TERRNO 411 -2.8%
GROK-47L 410 -2.8%
DSK-V-3E48BD 410 -2.6%
GPT-6L 407 -2.6%
GLM-53F 407 -2.6%
STEP-5 405 -2.6%
CL-FABL51XH 403 -4.7%
GPT-61TERRL 403 -2.9%
MIMO-V26F 401 -2.4%
CL-FABL51 399 -4.5%
CL-SN55M 395 -2.9%
CL-OP55L 393 -3.4%
MIST-LARG4 390 -2.7%
CL-FABL51H 386 -4.5%
CL-HK55M 386 -2.3%
GPT-6LUNAXH 377 -2.6%
MUSE-SPAROPE 375 -2.6%
MIST-LARG4M 371 -2.4%
DSK-V4P 365 -2.4%
GPT-6LUNAH 365 -2.1%
GLM-53L 364 -2.4%
CL-SN55L 362 -2.7%
GEM-38FL 361 -2.4%
GPT-6ASTRL 359 -4.5%
CL-FABL51M 359 -4.5%
QWEN-827B 349 -2.2%
CL-HK55L 347 -2%
MMAX-M3 345 -2%
GPT-6LUNAM 344 -2.3%
DSK-V-02811D 344 -2%
K2-HORI375BA 342 -2%
REFL-BEAM 338 -2%
QWEN-827BM 332 -1.8%
CL-FABL51L 329 -4.4%
QWEN-827BL 320 -1.8%
NEMO-35SUPEV 313 -1.9%
INKL 295 -1.7%
NVID-NEMO3UL 295 -1.3%
GEM-35FLITE 295 -1.3%
GPT-6LUNAL 287 -1.4%
GPT-6LUNANON 286 -1%
NANB-333B 285 -2.7%
QWEN-827BNON 282 -1.4%
COMM-APLUS 266 -1.1%
MUSE-GLIM 263 -1.1%
NEMO-35LIGH 261 -0.8%
GRAN-428B 258 -0.8%
MIST-SMAL4 252 -0.4%
INKL-SM 235 -2.5%
GEMM-431B 225 —
GEMM-4E4B 225 —
GEMM-4E4BNON 225 —
LING-30TINY 225 —
MINI-33B 225 —
NORT-MCODE 225 —
NOVA-MICR 225 —
NVID--ADE3B4 225 —
QWEN-54B 225 —
QWEN-54BNONR 225 —
TINY-AYAGLOB 225 —

Delayed ticker data. Last calculated 5 Nov 2026, 11:04 pm Sydney time.

← Back to feed

OpenAI GeneBench-Pro: Sol Pro Hits 31.5% on Biology Research Tasks — and Accidentally Reveals Three Unannounced Pro Models

OpenAI shipped GeneBench-Pro on June 30 and buried two stories inside one paper.

The benchmark itself is the headline that landed in biology circles: 129 computational research problems spanning genomics, quantitative biology, and translational medicine. Tasks modelled after real experimental workflows — treatment-effect estimation in a synthetic oncology registry, lncRNA dependency analysis from CRISPRi data, disease-effect estimation using cis-MVMR. External domain experts reviewed 82 of the 129 problems to verify they reflected real research and had identifiable correct answers.

Every problem is synthetic. Causal structures are known in advance, so answers grade deterministically against ground truth. No rubric ambiguity, no contamination from published literature. The point is to test judgment under ambiguity, not pattern matching against training data.

The Scores

GPT-5.6 Sol leads at 28.7% on highest reasoning — rising to 31.5% in Pro mode. For context, GPT-5 scored below 5% on the original GeneBench when OpenAI began building this benchmark. Every problem that sits below a 20% pass rate for the strongest models is, by design, where the ceiling is.

ModelPass Rate
GPT-5.6 Sol Pro31.5%
GPT-5.6 Sol28.7%
GPT-5.6 Terra Pro28.5%
GPT-5.6 Terra23.3%
GPT-5.6 Luna Pro23.6%
GPT-5.6 Luna16.5%
Claude Opus 4.816.0%
Gemini 3.5 Flash8.1%

External reviewers estimated a human expert would need 20-40 hours per problem. Inference cost on GeneBench-Pro runs to a few dollars per task. OpenAI describes the model-human cost ratio as the motivating argument for partial automation in research workflows — not replacement, but coverage of the long tail.

Test-time compute matters sharply. At the lowest reasoning setting, GPT-5.6 drops to single digits. At the highest, Sol clears 28.7%. Scaling reasoning budget was the primary driver of improvement on this benchmark.

The Pro Tier Leak

The more consequential reveal is in the results table. OpenAI’s paper names GPT-5.6 Luna Pro, Terra Pro, and Sol Pro as separate evaluated configurations — labelled “Pro (Extended)” runs. Until now, ChatGPT Pro has been a single top-tier option sitting above Plus. The paper implies a coming restructuring where Pro becomes its own three-model lineup, each mirroring the standard GPT-5.6 tier.

The performance gap between standard and Pro is real and consistent:

TierStandardPro (Extended)Gap
Luna16.5%23.6%+7.1 pts
Terra23.3%28.5%+5.2 pts
Sol28.7%31.5%+2.8 pts

Terra Pro at 28.5% essentially matches standard Sol at 28.7%. That would mean a mid-tier Pro configuration performs on par with the top standard configuration — a meaningful product-level distinction if this translates to ChatGPT.

One detail is missing from the paper: average token usage for Pro runs. OpenAI reports token counts for standard models (roughly 33,200 tokens for Sol at maximum reasoning) but omits them for Pro configurations. The authors say comparable accounting was unavailable. The more likely explanation is deliberate restraint — compute costs for Pro are not something OpenAI is ready to publish.

What the Benchmark Means

OpenAI flags that GeneBench-Pro could be saturated by year end. Based on observed trajectories from prior benchmarks, that is plausible. The current 31.5% ceiling is set by OpenAI’s own Pro model, which has not been publicly released. The benchmark is open: 10 representative problems are on Hugging Face, and a 50-question subset goes to Artificial Analysis for independent evaluation.

Until Artificial Analysis or other third parties publish independent runs on Anthropic, Google, and DeepSeek models, the comparative results should be treated as provisional. The benchmark infrastructure is OpenAI’s, the models are OpenAI’s, and the paper has not undergone external peer review. What it does clearly establish: computational biology now has a structured evaluation surface, and the current frontier sits well below human expert-level performance on research-grade judgment tasks.